Latest Advances

  • Condition: Macular Disease
  • Journal: Indian journal of ophthalmology
  • Treatment Used: Razumab
  • Number of Patients: 141
  • Published —
This study evaluated the effectiveness and safety of razumab for the treatment of macular (oval-shaped pigmented area near the center of the retina of the eye) disease.
  • Condition: Macular Edema Following Branch Retinal Vein Occlusion in Treatment -Naive Patients
  • Journal: Scientific reports
  • Treatment Used: Ranibizumab and Adjunct Laser
  • Number of Patients: 59
  • Published —
The purpose of the study was to assess the safety and effectiveness of ranibizumab with or without focal/grid laser in treatment-naive patients suffering from macular edema.
  • Condition: Ischemic Central Retinal Vein Occlusion
  • Journal: Vestnik oftalmologii
  • Treatment Used: Selective Panretinal Laser Photocoagulation
  • Number of Patients: 15
  • Published —
The study researched the outcomes of selective panretinal laser photocoagulation for ischemic central retinal vein occlusion.
  • Condition: Central Retinal Vein Occlusion
  • Journal: The Tokai journal of experimental and clinical medicine
  • Treatment Used: Anti-VEGF Injection
  • Number of Patients: 2
  • Published —
The study researched the outcomes of anti-VEGF injection in patients with central retinal vein occlusion.
  • Condition: Vitreous Hemorrhage from Unusual Giant Macular Tear
  • Journal: The Journal of international medical research
  • Treatment Used: Pars Plana Vitrectomy
  • Number of Patients: 1
  • Published —
This case report describes a patient with a vitreous hemorrhage that they developed from an unusual giant macular tear that was treated using a pars plana vitrectomy.
  • Condition: Hemi-Central Retinal Artery Occlusion
  • Journal: [Zhonghua yan ke za zhi] Chinese journal of ophthalmology
  • Treatment Used: Intra-Retinal Vein Cannulation without Tissue-Type Plasminogen activator
  • Number of Patients: 1
  • Published —
This case report describes a 19-year-old woman diagnosed with hemi-central retinal artery occlusion treated with intra-retinal vein cannulation without tissue-type plasminogen activator.
  • Condition: Orbital Abscess Caused by Exophiala Dermatitidis following Posterior Subtenon Injection of Triamcinolone Acetonide
  • Journal: BMC infectious diseases
  • Treatment Used: Surgical Debridement and Systemic Administration of Voriconazole
  • Number of Patients: 1
  • Published —
This case report describes a 69-year-old Japanese woman diagnosed with an orbital abscess caused by Exophiala dermatitidis following posterior subtenon injection of triamcinolone acetonide treated with surgical debridement and systemic administration of voriconazole.
  • Condition: Macular Edema
  • Journal: BioMed research international
  • Treatment Used: Ranibizumab
  • Number of Patients: 38
  • Published —
In this study, researchers evaluated the outcomes of using ranibizumab for the treatment of macular edema due to central and branch retinal vein occlusion in patients under 50.
  • Condition: Major and Macular Branch Retinal Vein Occlusion (BRVO)
  • Journal: BMC ophthalmology
  • Treatment Used: Intravitreal Lucentis Injection
  • Number of Patients: 43
  • Published —
This study assessed the effectiveness of intravitreal Lucentis injection on major and macular branch retinal vein occlusion (BRVO).
  • Condition: Macular Edema
  • Journal: The Cochrane database of systematic reviews
  • Treatment Used: Anti-VEGF Therapy
  • Number of Patients: 1631
  • Published —
In this study, researchers evaluated the safety and effectiveness of using anti-VEGF therapy for the treatment of macular edema due to branch retinal vein occlusion.
  • Condition: Macular Edema (ME) Secondary to Branch Retinal Vein Occlusion (BRVO)
  • Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
  • Treatment Used: Topical Triamcinolone Acetonide-Loaded Liposomes (TA_LF)
  • Number of Patients: 12
  • Published —
This study explored the safety and effectiveness of a topical ophthalmic triamcinolone acetonide-loaded liposome formulation (TA-LF) as primary therapy in patients with macular edema (ME) secondary to branch retinal vein occlusion (BRVO).
Showing 1-12 of 88